Dynasore: Powerful Dynamin GTPase Inhibitor for Endocytosis Research

Principle and Setup: Precision Inhibition of Dynamin-Dependent Endocytosis

Dynasore is a cell-permeable, noncompetitive dynamin GTPase inhibitor with an IC₅₀ of 15 µM, targeting dynamin1, dynamin2, and Drp1. By blocking GTP hydrolysis, Dynasore selectively inhibits dynamin-dependent endocytosis, vesicle scission, and downstream signal transduction pathways. Its reversible mechanism makes it indispensable for dissecting rapid endocytic events, protein trafficking, and synaptic vesicle cycling in both neuronal and non-neuronal cells. Dynasore is supplied as a solid and is soluble in DMSO (≥16.12 mg/mL), but insoluble in water or ethanol, so careful stock preparation and storage at -20°C are essential for consistent experimental results.

How Dynasore Works in Cellular Contexts

Dynasore’s inhibition of the dynamin GTPase signaling pathway has been validated in multiple cell types, including HL-1 cardiomyocytes, neurons, and kidney epithelial cells. It effectively blocks clathrin-mediated endocytosis, synaptic vesicle recycling, and transferrin uptake—processes fundamental to cell signaling, protein biosynthesis, and vesicle trafficking pathways. This makes Dynasore a go-to reagent for endocytosis research, cancer research, and neurodegenerative disease modeling where precise temporal control and reversibility are required.

Step-by-Step Workflow: Protocol Enhancements for Reliable Results

1. Stock Solution Preparation

• Weigh Dynasore (SKU A1605) and dissolve in DMSO at ≥16.12 mg/mL.
• Facilitate dissolution by warming at 37°C or brief sonication.
• Aliquot and store at -20°C; avoid repeated freeze-thaw cycles to maintain potency.

2. Working Solution and Cell Treatment

• Prepare working dilutions fresh each day, ensuring the final DMSO concentration in culture does not exceed 0.1–0.2% (v/v) to avoid cytotoxicity.
• Typical working concentrations range from 20–80 µM, with 80 µM often used for robust inhibition of dynamin-dependent endocytosis in mammalian systems.
• Incubate cells with Dynasore for 10–30 minutes prior to initiating endocytosis assays.

3. Experimental Readouts: Common Assays

• Transferrin Uptake Assay: Quantify inhibition of clathrin-mediated endocytosis using fluorescently labeled transferrin. Expect >90% inhibition at 80 µM within 15 minutes.
• Synaptic Vesicle Endocytosis: In neuronal cultures, Dynasore rapidly and reversibly blocks synaptic vesicle recycling, useful for dissecting neurotransmitter release mechanisms.
• Pathogen Entry Studies: As demonstrated by Wang et al. (2018), Dynasore effectively inhibits clathrin-mediated viral entry, confirming dynamin’s essential role in pathogen uptake.

Advanced Applications and Comparative Advantages

Applied Use-Cases

• Cancer Research: Dissect the role of endocytosis in receptor tyrosine kinase trafficking, oncogenic signaling, and drug resistance. Dynasore’s noncompetitive inhibition allows for rapid, reversible modulation, facilitating kinetic studies on the vesicle trafficking pathway.
• Neurodegenerative Disease Models: Interrogate synaptic vesicle endocytosis inhibition in models of Alzheimer’s or Parkinson’s, where altered dynamin function is implicated in disease progression.
• Signal Transduction Pathway Study: Unravel how endocytic blockade affects downstream pathways in immune signaling, growth factor responses, or metabolic regulation.

Data-Driven Insights and Literature Integration

In a seminal study by Wang et al. (2018), Dynasore at 80 µM significantly inhibited grass carp reovirus (GCRV) entry into CIK cells, supporting a dynamin-dependent, clathrin-mediated endocytosis mechanism. Viral titers were reduced by over 90% in Dynasore-treated cells compared to controls, highlighting its potency as a dynamin-dependent endocytosis inhibitor. Similar results have been reported in mammalian systems, where Dynasore’s rapid onset and reversibility enable fine control of endocytic events without detectable off-target cytotoxicity at standard working concentrations.

Comparative Review with Related Resources

• Dynasore in Context: Precision Inhibition for Endocytosis – This article complements our focus by delving into mechanistic insight and pathogen entry studies, further validating Dynasore’s unique capacity for dissecting viral and bacterial uptake pathways.
• Dynasore (SKU A1605): Streamlining Endocytosis and Vesicle Trafficking – Here, practical guidance on Dynasore’s deployment for cell viability and reproducibility is contrasted with alternative inhibitors, emphasizing APExBIO’s reputation for quality and supply reliability.
• Dynasore: A Powerful Dynamin GTPase Inhibitor for Endocytosis – This resource extends the discussion to protocol enhancements and advanced troubleshooting, offering scenario-driven solutions for optimizing assay reliability.

Troubleshooting and Optimization Tips

Common Pitfalls and Solutions

• Incomplete Dissolution: If Dynasore does not fully dissolve in DMSO, warm gently to 37°C or sonicate. Ensure no particulates remain before use.
• Precipitation in Culture: Avoid rapid dilution; add Dynasore slowly to pre-warmed medium with constant mixing. Filter-sterilize if necessary.
• Variable Inhibition: Confirm cell density and health; over-confluent or stressed cells may exhibit altered sensitivity. Optimize incubation time and concentration for each cell line.
• DMSO Toxicity: Keep DMSO at ≤0.2% (v/v) in final dilutions. Use vehicle controls to distinguish Dynasore-specific effects from solvent artifacts.

Assay Optimization Checklist

• Validate inhibition by including positive controls (e.g., transferrin uptake) and negative controls (DMSO only).
• Monitor recovery kinetics—Dynasore washout allows reversible assessment of endocytosis, critical for dynamic pathway studies.
• For long-term studies, assess cell viability post-treatment using MTT or similar assays to exclude delayed cytotoxicity.
• For high-content imaging, minimize background fluorescence by thorough washing post-Dynasore incubation.

Future Outlook: Innovations and Expanding Applications

The versatility of Dynasore continues to drive innovation in cellular trafficking, disease modeling, and drug development. Its rapid, reversible inhibition profile is being leveraged in live-cell imaging of vesicle trafficking pathways and in high-throughput screening for endocytosis-modulating drugs. Recent advances integrate Dynasore with CRISPR-based genetic screens, enabling dissection of compensatory mechanisms in the dynamin GTPase signaling pathway. In the context of emerging viral threats and targeted cancer therapies, Dynasore is poised to remain a cornerstone reagent for both fundamental and translational research.

For researchers seeking validated, high-quality reagents, Dynasore from APExBIO stands as the trusted choice, backed by extensive peer-reviewed data and reliable supply. By integrating careful protocol design, robust controls, and advanced troubleshooting, scientists can unlock the full potential of this noncompetitive GTPase inhibitor in their endocytosis research.